In the 4T1 xenograft tumor model, LINCL significantly increased the cell surface expression of CRT, promoted HMGB1 release (Fig. 4c, d), and facilitated DC maturation in the tumor-draining lymph nodes to a greater extent than were realized in the laser-insensitive group. The gene discussed is CALR; the disease is neoplasm.